Skip to search formSkip to main contentSkip to account menu

maraviroc 300 MG Oral Tablet [Selzentry]

Known as: Maraviroc 300 mg ORAL TABLET, FILM COATED [SELZENTRY], Selzentry 300 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

14 relations
Aluminum OxideHYDROGENATED SOYBEAN LECITHINIndigo CarmineMagnesium stearate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Switching Undetectables to Once Daily Selzentry®: The SUDS Study
CD4 Count Result •St. Hope Foundation’s database was queried to identify HIV positive patients on non-MVC containing regimens… 
2011
2011
Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study
Abstract 1011 Inhibition of lymphocyte trafficking early after allogeneic stem cell transplantation (SCT) may prevent GvHD… 
2010
2010
Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist
Abstract 673 Inhibition of lymphocyte trafficking early after allogeneic stem cell transplantation (SCT) could limit T cell… 
2009
2009
Diseño, selección y síntesis de nuevos inhibidores de entrada del VIH
La sida es una malaltia causada pel VIH, que ataca a les cel·lules del sistema immunitari. Actualment s'estima que viuen uns 33… 
2008
2008
Standardizing the Decision Process to Personalize a Therapy with a Theranostic : The Options for Test Index ( OFT i )
While the top pharmaceutical companies have all made investments at an R&D stage in biomarkers and genetics to aid drug selection… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)